OTTAWA, July 07, 2020 (GLOBE NEWSWIRE) — Leonovus Inc. (“Leonovus” or the “Company”) (TSXV: LTV) today provides an update regarding its Consolidata […]
Zai Lab Granted Exclusive Rights to Develop and Commercialize Repotrectinib in Greater ChinaTurning Point to Receive $25 Million Upfront, Potential […]